UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1422-1428

2012

Volltextzugriff (PDF)

Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study

Journal of clinical oncology, 2014-01, Vol.32 (1), p.34-43

2014

Volltextzugriff (PDF)

International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

Journal of clinical oncology, 2024-07, Vol.42 (19), p.2271-2280

2024

Volltextzugriff (PDF)

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1370-1379

2019

Volltextzugriff (PDF)

Programmed death-1 blockade in mismatch repair deficient colorectal cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.103-103

2016

Volltextzugriff (PDF)

Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3387-3394

2008

Volltextzugriff (PDF)

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Journal of clinical oncology, 2019-06, Vol.37 (18), p.1558-1565

2019

Volltextzugriff (PDF)

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases

Journal of clinical oncology, 2015-06, Vol.33 (17), p.1881-1888

2015

Volltextzugriff (PDF)

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603

2020

Volltextzugriff (PDF)

Managing Central Nervous System Spread of Lung Cancer: The State of the Art

Journal of clinical oncology, 2022-02, Vol.40 (6), p.642-660

2022

Volltextzugriff (PDF)

Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1527-1533

2012

Volltextzugriff (PDF)

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3376-3382

2012

Volltextzugriff (PDF)

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1070-1077

2017

Volltextzugriff (PDF)

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2693-2701

2018

Volltextzugriff (PDF)

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer

Journal of clinical oncology, 2018-04, Vol.36 (12), p.1199-1206

2018

Volltextzugriff (PDF)

Revised International Pediatric Non-Hodgkin Lymphoma Staging System

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2112-2118

2015

Volltextzugriff (PDF)

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Journal of clinical oncology, 2018-12, Vol.36 (34), p.3353-3360

2018

Volltextzugriff (PDF)

African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?

Journal of clinical oncology, 2013-08, Vol.31 (24), p.2991-2997

2013

Volltextzugriff (PDF)

Radiosurgery for Small-Cell Brain Metastases: Challenging the Last Bastion of Preferential Whole-Brain Radiotherapy Delivery

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3587-3591

2020

Volltextzugriff (PDF)

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2022-10, Vol.40 (29), p.JCO2200227-3393

2022

Volltextzugriff (PDF)

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-09, Vol.29 (26), p.3567-3573

2011

Volltextzugriff (PDF)

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1138-1144

2010

Volltextzugriff (PDF)

Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology

Journal of clinical oncology, 2007-09, Vol.25 (26), p.4104-4109

2007

Volltextzugriff (PDF)

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1992-1998

2023

Volltextzugriff (PDF)

1 – 25 von 1.485

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.485)
Mit Volltextzugriff
(1.419)

Publikationsform

Artikel
(1.485)

Sprache

Englisch
(1.485)
Japanisch
(81)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(254)
Oncology
(251)
Life Sciences & Biomedicine
(247)
Science & Technology
(247)
Female
(195)
Middle Aged
(177)
Male
(161)
Biological And Medical Sciences
(159)
Medical Sciences
(159)
Aged
(151)
Adult
(142)
Tumors
(99)
Aged, 80 And Over
(68)
Original Reports
(66)
Treatment Outcome
(60)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(52)
Prognosis
(47)
Pharmacology. Drug Treatments
(45)
Antineoplastic Agents
(44)
Survival Analysis
(42)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.485)
Journals@Ovid Full Text
(1.485)
NUS Single-Journal Subscriptions
(1.485)
IngentaConnect Journals
(544)
Ingenta.com
(544)
MEDLINE
(254)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(2)

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer

Programmed death-1 blockade in mismatch repair deficient colorectal cancer

Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Managing Central Nervous System Spread of Lung Cancer: The State of the Art

Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer

Revised International Pediatric Non-Hodgkin Lymphoma Staging System

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?

Radiosurgery for Small-Cell Brain Metastases: Challenging the Last Bastion of Preferential Whole-Brain Radiotherapy Delivery

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

Aktive Filter

Suchergebnisse filtern